October 15, 2026

Neurogene Inc. (NGNE) Stock Report: Analyst Consensus Suggests a Staggering 251% Upside Amid Clinical Trials

Neurogene Inc. (NASDAQ: NGNE), a clinical-stage biotechnology company, is garnering significant attention from investors due to its promising genetic therapies for rare neurological diseases. With a..

Spok Holdings, Inc. (SPOK) Stock Analysis: Evaluating Its 11.56% Dividend Yield Amidst Market Uncertainties

Spok Holdings, Inc. (NASDAQ: SPOK), a key player in the health information services sector, offers a compelling case for dividend-focused investors despite its recent market performance...

Asure Software Inc (ASUR) Stock Analysis: Potential Upside of 83% with Strong Buy Ratings

Asure Software Inc (NASDAQ: ASUR), a notable player in the technology sector specializing in cloud-based Human Capital Management (HCM) solutions, is capturing investor attention with its..

Nerdy Inc. (NRDY) Stock Analysis: Uncovering a Potential 298.29% Upside in the Online Learning Sector

As an individual investor exploring opportunities in the technology sector, Nerdy Inc. (NRDY) presents a compelling case, primarily due to its significant potential upside. Known for..

Vanda Pharmaceuticals (VNDA) Stock Analysis: Exploring a Potential 178% Upside

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) presents itself as a compelling opportunity within the biotechnology sector, particularly for investors interested in high-reward scenarios. Despite recent challenges, the..

Mereo BioPharma Group plc (MREO): Analyst Ratings Highlight a Potential 536.98% Upside

Mereo BioPharma Group plc (NASDAQ: MREO), a biopharmaceutical entity headquartered in London, is capturing investor attention with its robust pipeline focused on treating rare diseases. Despite..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring a Potential 1,833.70% Upside in the Biotechnology Sector

Heron Therapeutics, Inc. (NASDAQ: HRTX) might seem like just another name in the vast world of biotechnology, but recent data presents a compelling case for investors..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Navigating a 971% Potential Upside in Biotech

Gossamer Bio, Inc. (NASDAQ: GOSS), a prominent player in the biotechnology sector focused on treating pulmonary hypertension, presents a compelling yet complex investment opportunity. With a..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Unpacking the 332.91% Potential Upside

Investors eyeing the biotechnology sector may find Abeona Therapeutics Inc. (NASDAQ: ABEO) a compelling option given its striking potential upside of 332.91%. This commercial-stage biopharmaceutical company,..

AMTD Digital Inc. (HKD) Stock Analysis: Navigating a 340.90% Revenue Surge in the Tech Sector

As the digital landscape continues to evolve, AMTD Digital Inc. (HKD) stands as a compelling player in the Technology sector, particularly within the Software – Application..

Marti Technologies (MRT) Stock Analysis: Unveiling a Potential 184.75% Upside in Turkey’s Tech Sector

Marti Technologies, Inc. (NASDAQ: MRT) has emerged as a promising contender in the technology sector, specifically within the software application industry. Based in Turkey, this dynamic..

Nyxoah SA (NYXH)

⚠️ No article content returned.

..

Candel Therapeutics, Inc. (CADL) Stock Analysis: A Biotech with 139.80% Potential Upside

Candel Therapeutics, Inc. (CADL), a clinical-stage biopharmaceutical company, is capturing investor attention with its promising potential in the biotechnology sector. Headquartered in Needham, Massachusetts, and incorporated..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Navigating Growth with a 3.10% Upside Potential

Cytek Biosciences, Inc. (NASDAQ: CTKB), a healthcare sector player specializing in medical devices, offers intriguing prospects for investors focused on the cell analysis market. With a..

NRC Health (NRC) Stock Analysis: A Promising 27% Upside with Strong ROE and Dividend Yield

NRC Health (NASDAQ: NRC) is a notable player in the healthcare sector, specializing in health information services. With a robust market cap of $452.31 million, NRC..

Cartesian Therapeutics (RNAC) Stock Analysis: A 431% Potential Upside in Biotech

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is garnering attention for its innovative approach in the biotechnology sector, particularly in the development of mRNA cell therapies targeting autoimmune..

Varex Imaging Corporation (VREX) Stock Analysis: Navigating Growth in the Medical Devices Sector with a 2.77% Upside

Varex Imaging Corporation (NASDAQ: VREX), a prominent player in the healthcare sector, specializes in the design and manufacture of X-ray imaging components. With a current market..

Pacific Biosciences of California (PACB) Stock Analysis: Unpacking the 20.60% Potential Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a key player in the Healthcare sector’s Medical Devices industry, offers a compelling investment case for those interested in..

Senseonics Holdings, Inc. (SENS) Stock Analysis: 68.72% Potential Upside Sparks Investor Interest

For investors eyeing the healthcare sector, Senseonics Holdings, Inc. (SENS) presents a compelling opportunity with its innovative approach to glucose monitoring systems. This Maryland-based company, with..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a 24% Potential Upside Amid Strong Buy Ratings

Alpha Teknova, Inc. (NASDAQ: TKNO) stands out in the healthcare sector, particularly within the drug manufacturers’ industry, as it continues to catch the eye of investors..

Search

Funds

October 15, 2026

Search

Funds

October 15, 2026

FTSE 100

Funds